These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2071678)

  • 1. AIDS, activism, and ethics.
    Rothman DJ; Edgar H
    Hosp Pract (Off Ed); 1991 Jul; 26(7):135-42. PubMed ID: 2071678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New rules for new drugs: the challenge of AIDS to the regulatory process.
    Edgar H; Rothman DJ
    Milbank Q; 1990; 68(Suppl. 1):111-42. PubMed ID: 11650413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient access to experimental drugs and AIDS clinical trial designs: ethical issues.
    Schüklenk U; Hogan C
    Camb Q Healthc Ethics; 1996; 5(3):400-9. PubMed ID: 8862826
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk versus risk: decision-making dilemmas of drug regulation in the United States and Germany.
    Daemmrich A; Krucken G
    Sci Cult (Lond); 2000 Dec; 9(4):505-34. PubMed ID: 15988846
    [No Abstract]   [Full Text] [Related]  

  • 5. Methodological issues in AIDS clinical trials. Statutory and regulatory framework for drug approval.
    Burlington DB
    J Acquir Immune Defic Syndr (1988); 1990; 3 Suppl 2():S4-9. PubMed ID: 2231300
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.
    Rossen BR
    Food Drug Law J; 2009; 64(1):183-223. PubMed ID: 19998746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hiding behind agency discretion: the Food and Drug Administration's personal use drug importation policy.
    Reichertz PS; Friend MS
    Cornell J Law Public Policy; 2000; 9():493-521. PubMed ID: 11067734
    [No Abstract]   [Full Text] [Related]  

  • 8. AIDS and the FDA: an ethical case for limiting patient access to new medical therapies.
    Shorr AF
    IRB; 1992; 14(4):1-5. PubMed ID: 11651391
    [No Abstract]   [Full Text] [Related]  

  • 9. When science and passion meet: the impact of AIDS on research.
    Pripstein J
    CMAJ; 1993 Feb; 148(4):638-42. PubMed ID: 8431829
    [No Abstract]   [Full Text] [Related]  

  • 10. Second thoughts: do the FDA's responses to a fatal drug trial and the AIDS activist community's doubts about early access to drugs hint at a shift in basic FDA policy?
    Lovell MC
    Food Drug Law J; 1996; 51(2):273-94. PubMed ID: 11820202
    [No Abstract]   [Full Text] [Related]  

  • 11. AIDS--challenges to basic and clinical biomedical research.
    Fauci AS
    Acad Med; 1989 Mar; 64(3):115-9. PubMed ID: 2647088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDA 'pushing envelope' on AIDS drug.
    Cotton P
    JAMA; 1991 Aug; 266(6):757-8. PubMed ID: 1907668
    [No Abstract]   [Full Text] [Related]  

  • 13. The fast track: federal agencies and the political demand for AIDS drugs.
    Foreman CH
    Brookings Rev; 1991; 9(2):30-7. PubMed ID: 10110828
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA approves AIDS drug.
    Am Pharm; 1992 Sep; NS32(9):13-4. PubMed ID: 1332462
    [No Abstract]   [Full Text] [Related]  

  • 15. The fast track toward new AIDS drugs.
    Long K; Long R
    Nurse Pract Forum; 1991 Jun; 2(2):80-1. PubMed ID: 1840952
    [No Abstract]   [Full Text] [Related]  

  • 16. Investigational new drug, antibiotic, and biological product applications; clinical hold and termination--FDA. Final rule.
    Fed Regist; 1992 Apr; 57(73):13244-9. PubMed ID: 10118458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug approval and AIDS: benefits for the elderly.
    Rothman DJ; Edgar H
    Health Aff (Millwood); 1990; 9(3):123-30. PubMed ID: 2227773
    [No Abstract]   [Full Text] [Related]  

  • 18. A faster track for AIDS drugs?
    Kosterlitz J
    Natl J (Wash); 1989 Jul; 21(30):1931. PubMed ID: 10293944
    [No Abstract]   [Full Text] [Related]  

  • 19. A shot in the arm for an AIDS vaccine.
    Newsweek; 1998 Jun; 131(24):62. PubMed ID: 10180631
    [No Abstract]   [Full Text] [Related]  

  • 20. Desperation drugs. Frustrated AIDs patients are spurring the FDA to relax the rules of the game.
    Begley S; Hager M; Wilson L
    Newsweek; 1989 Aug; 114(6):48-9, 51. PubMed ID: 10293942
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.